Ain Medicare Combined UDV Nebuliser Solution

Ain Medicare Combined UDV Nebuliser Solution contains Ipratropium Bromide and Salbutamol (as Salbutamol Sulfate) and is presented as a solution. It is supplied in a pack size of 2.5ml x60.

It is classified as a non-prescription medicine, so no prescription is needed to order it. Under Malaysian rules for medicine information, this page carries product, safety and handling information only.

You can consult a doctor or pharmacist online on DoctorOnCall about this product before or after you order. Every order is checked by a registered pharmacist before it is delivered. Always read the label and the leaflet supplied with the pack.

Ain Medicare Combined UDV Nebuliser Solution is administered using a nebuliser machine as instructed by the prescribing doctor or respiratory therapist: the contents of one unit-dose vial are emptied into the nebuliser chamber, and the mist is inhaled through a mouthpiece or, if a face mask must be used, care should be taken to avoid spraying the mist directly into the eyes. The vial should not be swallowed or injected, and any unused solution remaining in an opened vial should be discarded rather than stored for later use.

The dose and frequency of Ain Medicare Combined UDV Nebuliser Solution are determined by the prescribing doctor based on the severity of the respiratory condition, and typically involve nebulising the contents of one unit-dose vial several times a day as needed or as scheduled by the doctor. The dose should never be increased or repeated more frequently than prescribed without first speaking to the doctor, as excessive use of the salbutamol component can lead to significant side effects.

Ain Medicare Combined UDV Nebuliser Solution typically has a shelf life of around 18 to 24 months from the date of manufacture when stored correctly and protected from light in its original foil pouch. Always check the expiry date printed on the individual vial and outer carton before use.

Store below 25°C, protected from light, and keep the unit-dose vials in their original foil pouch until immediately before use, as exposure to light can degrade the active ingredients. Keep out of the reach and sight of children, and do not use a vial if the solution appears discoloured or cloudy.

• Known hypersensitivity to ipratropium bromide, atropine-like compounds, salbutamol, or any other ingredient in the solution
• Hypertrophic obstructive cardiomyopathy
• Uncontrolled cardiac arrhythmias, particularly with the salbutamol component
• Should be used with caution and close monitoring in patients with pre-existing heart disease, high blood pressure, diabetes, or an overactive thyroid

• Concurrent use with other beta-agonist bronchodilators may increase the risk of cardiovascular side effects such as a rapid heartbeat
• Beta-blocker medicines can reduce the bronchodilating effect of salbutamol and should be discussed with the prescribing doctor
• Certain medicines for irregular heart rhythm or depression (e.g. monoamine oxidase inhibitors, tricyclic antidepressants) may increase the risk of side effects when combined with salbutamol
• Low potassium levels may be worsened if this solution is used together with certain diuretics, steroids, or theophylline

• Use a well-fitted mouthpiece rather than a face mask where possible to avoid accidental contact of the mist with the eyes
• Rinse the mouth after use if a bitter taste or dry mouth occurs
• Never increase the dose or frequency of nebulisation beyond what the doctor has prescribed, even if symptoms feel severe
• Clean and maintain the nebuliser equipment according to the manufacturer’s instructions to ensure the correct dose is delivered
• Seek urgent medical attention if breathlessness worsens despite nebuliser use, as this may indicate a serious asthma or COPD flare-up

Ain Medicare Combined UDV Nebuliser Solution requires an online medical consultation through DoctorOnCall before it can be dispensed in Malaysia and Singapore, as this combination bronchodilator is intended for patients with an established diagnosis of asthma or COPD under a doctor’s ongoing supervision. Patients with heart disease, high blood pressure, diabetes, or thyroid conditions should ensure their doctor is aware of these conditions, and care should always be taken to avoid spraying the nebulised mist directly into the eyes, particularly when a face mask is used, as this can precipitate acute eye problems.